Vaccine Increases PFS for Metastatic Tumors.

Vaccine Increases PFS for Metastatic Tumors.

Publication date: Aug 08, 2019

A vaccine that targets tumor neoantigens may improve the effectiveness of nivolumab. A trial that included patients with metastatic melanoma, non-small cell lung cancer, and bladder cancer found that progression-free survival was longer than in historical controls. The vaccine also stimulated tumor-specific T cells.

___. Vaccine Increases PFS for Metastatic Tumors. 23702. 2019 Cancer Discov.

Concepts Keywords
Bladder
Lung Cancer
Melanoma
Tumor
Vaccine

Semantics

Type Source Name
pathway BSID Bladder cancer
pathway BSID Bladder Cancer
disease DOID bladder cancer
disease MESH bladder cancer
pathway BSID Non-small cell lung cancer
disease DOID non-small cell lung cancer
disease MESH non-small cell lung cancer
pathway BSID Melanoma
disease DOID melanoma
disease MESH melanoma
drug DRUGBANK Nivolumab
disease MESH Tumors

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *